liver-diseases

Documents about liver-diseases

• Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.#864362ClinicalTrials.gov
• Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen#866757ClinicalTrials.gov
• Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment#67801ClinicalTrials.gov
• Changes in the Lipidomic, Immunological and miRNA Profile in Patients Undergoing a Dietary Program or Bariatric Surgery#904003ClinicalTrials.gov
• Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic Disorders#878917ClinicalTrials.gov
• Mild Hypothermia and Acute Kidney Injury in Liver Transplantation#825517ClinicalTrials.gov
• Clinical Benefits of B-Flow Ultrasound#158094ClinicalTrials.gov
• NAFLD Among Patients With Type 2 Diabetes and CKD#481726ClinicalTrials.gov
• Avatrombopag for Thrombocytopenia in People With Cancer#830324ClinicalTrials.gov
• Repeatability and Reproducibility of Quantitative MRCP#897648ClinicalTrials.gov
• A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)#908572ClinicalTrials.gov
• The chinese herbal decoction danggui buxue tang inhibits angiogenesis in a rat model of liver fibrosis.#341982Apollo
• Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)#1008167ClinicalTrials.gov
• Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study#203167Recep Tayyip Erdoğan University Institutional Repository
• Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)#848711ClinicalTrials.gov
• The Effect and Safety of the Four Points Transversus Abdominis Plane Block#873641ClinicalTrials.gov
• Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients#642241eScholarship
• Assessing liver and iron markers in steady state pediatric SCD patients to ascertain the hepatic consequences of hemotransfusion: A case-control study in Ghana#197590Research Online
• A tale of dual role: HECT‑type E3 ubiquitin ligase mechanisms in liver diseases (Review).#25697NCBI PubMed Central
• PFAS exposure modulates mitochondrial susceptibility in steatotic hepatocytes#280366HAL (France)
• Lipoprotein and Apolipoproteins With Metabolic Liver Diseases#873696ClinicalTrials.gov
• Influenza Vaccine in Pediatric Transplant Subjects#904348ClinicalTrials.gov
• Electronic Record Assimilation and Subsequent Eradication of Hepatitis C#993082ClinicalTrials.gov
• Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study#362535Recep Tayyip Erdoğan University Institutional Repository
• Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection#190648UNSWorks Repository
• A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)#343751ClinicalTrials.gov
• Plasma Folate, Vitamin B12, and Homocysteine and Cancers of the Esophagus, Stomach, and Liver in a Chinese Population#814636eScholarship
• A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers#143790ClinicalTrials.gov
• Types of genotypes in progressive familial intrahepatic cholestasis and liver transplantation: A meta-analysis of observational studies#248080PLOS
• Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.#474833ClinicalTrials.gov
• Herbal remedies for hepatic diseases: A review of medicinal herbs in the treatment of liver disorders.#4402NCBI PubMed Central
• North American Study for the Treatment of Refractory Ascites (NASTRA)#154819ClinicalTrials.gov
• Early Tracking of Childhood Health Determinants (ETCHED) Study#398281ClinicalTrials.gov
• Challenges in the care of rare vascular liver diseases: Insights from patients, health care providers, and patient organizations#665105HAL (France)
• Half-life of Plasma Phytosterols in Preterm Infants on Parenteral Nutrition#869345ClinicalTrials.gov
• Influence of Sarcopenia on the Course of the Diseases#870213ClinicalTrials.gov
• Hepatic Lipid Metabolism-Alcohol Use Disorder#886475ClinicalTrials.gov
• A Real World Study of Polyene Phosphatidylcholine Injection for the Prevention and Treatment of DILI in Patients With Malignant Hematological Diseases#860794ClinicalTrials.gov
• Metabolic risk and metabolic dysfunction–associated steatotic liver disease and steatohepatitis in cognitive decline: A retrospective cohort study#355242PLOS
• A Trial for Comparing Rifaximin, Probiotic and L-ornithine- L Aspartate With Lactulose in Overt Hepatic Encephalopathy.#836853ClinicalTrials.gov
• Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)#825350ClinicalTrials.gov
• bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC#872246ClinicalTrials.gov
• Vitamin E Dosing Study#903778ClinicalTrials.gov
• Fluorescence Spectroscopy for Gut Permeability Assessment#862042ClinicalTrials.gov
• Natural History of Post-transfusion Non-A, Non-B Hepatitis#883050ClinicalTrials.gov
• Rabies Treatment by Exposure of Patient to X-Ray#888970ClinicalTrials.gov
• A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib#1007286ClinicalTrials.gov
• In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease#780484eScholarship
• Iron Depletion Therapy for Type 2 DM and NAFLD#303652ClinicalTrials.gov
• Study on Liver Sinusoidal Endothelial Cell Fenestrations Based on Cellular Omics-Structure Integration Technology and Its Application in Metabolic Diseases#314141bioRxiv / medRxiv